Welcome to our dedicated page for Delek Us Hldgs SEC filings (Ticker: DK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Delek US Holdings, Inc. (NYSE: DK) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret them. Delek US uses Form 8-K filings to furnish quarterly earnings releases, dividend announcements, investor presentations, and earnings call slides, giving investors a structured view of its financial condition and strategic messaging.
Through Item 2.02 of Form 8-K, Delek US reports results of operations and financial condition, including net income or loss, Adjusted net income, Adjusted EBITDA, and segment-level performance for refining and logistics. These filings often reference non-GAAP measures such as refining margin, adjusted refining margin, refining production margin, and net debt, along with reconciliations to GAAP metrics described in accompanying tables.
Item 7.01 Regulation FD disclosures in Delek US 8-Ks typically include earnings call slides and investor presentations. The company notes that these materials are furnished, not filed, and may be used in presentations to existing and prospective investors. Item 8.01 is used for other events, such as Board-approved quarterly dividends per share, with details on record and payment dates.
On this page, Stock Titan’s AI summarizes the key points from each filing so users can quickly understand what changed in Delek US’s business, capital allocation, and midstream relationship with Delek Logistics Partners, LP. Real-time updates from EDGAR ensure that new 8-Ks and other forms appear promptly, while AI-generated highlights help clarify complex sections, such as non-GAAP definitions and regulatory language, without replacing the need to review the full original documents.
Delek US Holdings, Inc. President & CEO Avigal Soreq reported selling a total of 50,000 shares of common stock on March 3, 2026 in three open-market transactions. The weighted average sale prices were $41.71, $40.90, and $39.85 per share, each reflecting multiple trades within stated price ranges. These transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted on December 3, 2025. After these sales, Soreq directly holds 251,678 shares of Delek US common stock.
DK affiliate reported a resale notice under Section 144. The filing records a sale of $315,749 for 7,343 common shares by Shlomo Zohar on 03/04/2026. The filing also lists multiple past restricted stock vesting entries with individual share counts and dates as context.
Delek US Holdings Inc filed a Form 144 reporting planned sales of Common stock related to compensatory vesting. The filing lists multiple vesting dates and share quantities tied to compensatory payments, including 27,303 shares on 02/26/2026 and 3,912 shares on 02/11/2026.
Ezra Uzi Yemin submitted a Form 144 notice reporting proposed sales of common shares through J.P. Morgan Securities LLC on the NYSE. The filing lists transactions tied to transfers on 01/30/2013 (22,077 shares) and 03/09/2019 (44,434 shares) as examples shown.
DK filed a Form 144 notice indicating a proposed sale of common stock through Fidelity Brokerage Services LLC. The filing lists multiple restricted‑stock vesting lots, including 1,187 shares vested 03/10/2018 and 1,102 shares vested 12/10/2018, among others.
DK reported a Form 144 notice indicating proposed sales of restricted common stock by an affiliate. The filing lists planned sales tied to restricted stock vesting, including 500 shares vesting on 11/12/2015, 1,712 shares on 12/10/2015, 1,723 shares on 12/10/2016, and 1,457 shares on 12/10/2024. The broker listed is Fidelity Brokerage Services LLC.
Fidelity Brokerage Services LLC submitted a Form 144 notice reporting 50,000 common shares related to proposed sales on 03/03/2026 on the NYSE. The filing lists multiple prior restricted stock vesting events totaling individual lot sizes (for example, 10,382 on 03/10/2023 and 6,747 on 09/10/2024) tied to compensation. The notice records an aggregate dollar figure of 2054306.97 associated with the filing.
A director of Delek US Holdings, Inc. reported acquiring 103,701 shares of common stock on 02/27/2026 through a transaction coded “M” at a price of $38.11 per share. After this transaction, the director directly owns 258,420 shares and indirectly holds 679,656 shares through Yemin Investments.